advanced search

PREFILLED SYRINGES

UNDERSTANDING PATIENT PREFERENCES FOR SUSTAINABLE ON-BODY DELIVERY SYSTEMS
SUSTAINABILITY
Stevanato Group
UNDERSTANDING PATIENT PREFERENCES FOR SUSTAINABLE ON-BODY DELIVERY SYSTEMS
Stevanato Group examines how semi-reusable, modular designs like its Vertiva 10 mL on-body delivery system can reconcile patient demands for ease of use with growing expectations for sustainability, sharing new UK preference data and lifecycle analysis that reveal significant waste and emissions reductions.
INTRODUCING THE TERUMO INJECTION FILTER NEEDLE – A FIRST STEP OF THE INFINO™ DEVELOPMENT PROGRAMME
INJECTION
Thomas Isaac
Terumo Medical Care Solutions
INTRODUCING THE TERUMO INJECTION FILTER NEEDLE – A FIRST STEP OF THE INFINO™ DEVELOPMENT PROGRAMME
Thomas Isaac considers the issues associated with injection to highly sensitive areas, such as the vitreous body, and the potential to optimise needle design and features to address these issues, discussing the key features of Terumo’s Injection Filter Needle, indicated for hypodermic and intravitreal injections within this context.
THE RISE OF LARGE-VOLUME SUBCUTANEOUS ADMINISTRATION OF BIOPHARMACEUTICALS, AND DELIVERY IMPLICATIONS
INJECTION
Dr Andreas Schneider
Ypsomed
THE RISE OF LARGE-VOLUME SUBCUTANEOUS ADMINISTRATION OF BIOPHARMACEUTICALS, AND DELIVERY IMPLICATIONS
Andreas Schneider and Jakob Lange consider the SC administration of larger volumes of biopharmaceuticals in the pharma industry and summarise a recent study that reviews clinical-stage and approved IV and SC biopharmaceuticals to provide valuable guidance for new product development, as well as for marketing and commercialisation strategies in the rapidly evolving large-volume SC landscape.
CONTAINER SELECTION FOR A HIGHLY SENSITIVE DRUG PRODUCT: A SUCCESS STORY
INJECTION
Enrico Barichello
Stevanato Group
CONTAINER SELECTION FOR A HIGHLY SENSITIVE DRUG PRODUCT: A SUCCESS STORY
Enrico Barichello discusses Stevanato Group’s collaboration with a leading pharmaceutical company to identify a suitable container for a high-concentration monoclonal antibody. The partnership addressed key challenges and contributed to maintaining the drug’s stability and integrity throughout its lifecycle.
DRUG DELIVERY TRENDS FOR 2025
EXPERT VIEW
Tom Oakley
DRUG DELIVERY TRENDS FOR 2025
Tom Oakley and Alex Vasiev look back at how the trends anticipated for 2024 played out in reality and look forward to four major trends expected to influence the drug delivery industry in 2025.
510(k) CLEARED, USER-FILLED MICRODOSING DEVICE FOR OPHTHALMIC AND OTHER APPLICATIONS
PREFILLED SYRINGES
Dr Gautam Shetty
Congruence Medical Solutions
510(k) CLEARED, USER-FILLED MICRODOSING DEVICE FOR OPHTHALMIC AND OTHER APPLICATIONS
Gautam Shetty discusses unmet drug delivery needs in applications requiring accurate and precise microlitre-scale doses,going on to detail how the Congruence Medical’s recently cleared Microliter Dosing Syringe can bring the benefits of advanced syringe materials and performance to these applications.
TUB & NEST – PRECISION AND EFFICIENCY IN DRUG DELIVERY
PREFILLED SYRINGES
Ivana Thiesson
Fischer Söhne
TUB & NEST – PRECISION AND EFFICIENCY IN DRUG DELIVERY
Ivana Thiesson and Jörg Sander applied marketing discuss the benefits of Fischer Söhne’s “Tub & Nest” format for packaging prefilled syringes, including design flexibility and precise cleanroom manufacturing.
TESTING SYRINGES & INJECTION DEVICES: SOLUTIONS THAT BOOST EFFICIENCY
INJECTION
Peter Schmidt
ZwickRoell
TESTING SYRINGES & INJECTION DEVICES: SOLUTIONS THAT BOOST EFFICIENCY
Peter Schmidt discusses ZwickRoell’s offerings in the arena of testing systems for injectable drug delivery systems, in particular highlighting the advantages of automation for providing reliable, reproducible results.
Interview: Sustainability at the Heart of Aptar Pharma’s Expansion
INTERVIEW
Audrey Chardonnet
Aptar Pharma
Interview: Sustainability at the Heart of Aptar Pharma’s Expansion
Audrey Chardonnet discusses the centrality of sustainability to Aptar Pharma’s expansion strategy, going into detail on how, by improving its practices and investing in its infrastructure, the company works towards reducing the environmental impact of injectable drug delivery solutions manufacturing.
DEVICE SELECTION: INJECTION VOLUMES FOR SUBCUTANEOUS ADMINISTRATION
INJECTION
Dr Nicolas Brandes
ten23 health
DEVICE SELECTION: INJECTION VOLUMES FOR SUBCUTANEOUS ADMINISTRATION
Nicolas Brandes, Andrea Allmendinger and Hanns-Christian Mahler explore the critical considerations for subcutaneous injection volume, beginning with the historical and scientific perspectives on injection volume before delving into the challenges of determining volume ranges and their associated fill volumes.
VERSATILITY, SUSTAINABILITY AND DIGITALISATION IN ONE SMART HANDHELD INJECTION PLATFORM
INJECTION
Dr Leonard Chu
Altek Medical
VERSATILITY, SUSTAINABILITY AND DIGITALISATION IN ONE SMART HANDHELD INJECTION PLATFORM
Leonard Chu discusses three trends in self-administration that are aligned with emerging smart devices – device versatility, sustainability and digitalisation – and the benefits offered by the Alcee injection platform.
BONDING TECHNOLOGIES FOR INJECTION DEVICES – A QUICK OVERVIEW
INDUSTRIALISATION
Hisham Jamal
teamtechnik
BONDING TECHNOLOGIES FOR INJECTION DEVICES – A QUICK OVERVIEW
Hisham Jamal and Carsten Köhler discuss some of the bonding technologies used for medical devices – highlighting their unique strengths, limitations and suitability.
SUBCUTANEOUS DRUG DELIVERY: ADAPTING TO HIGH-VISCOSITY, LARGE-VOLUME DEMANDS
INJECTION
Thomas Fontanellaz
Ypsomed
SUBCUTANEOUS DRUG DELIVERY: ADAPTING TO HIGH-VISCOSITY, LARGE-VOLUME DEMANDS
Thomas Fontanellaz, Reto Jost and Andreas Schneider discuss how Ypsomed is addressing the growing need for subcutaneous injections that accommodate higher volumes and viscosities, with innovative self-injection devices designed to enhance patient comfort and adherence.
STREAMLINING THE TESTING PROCESS FOR AUTOINJECTOR DEVICES
INJECTION
Landon Goldfarb
Instron
STREAMLINING THE TESTING PROCESS FOR AUTOINJECTOR DEVICES
Landon Goldfarb highlights the challenges of autoinjector testing and the importance of drawing on the experience of customers when it comes to drug delivery device innovation.
INTERVIEW with Scott Ariagno, EdgeOne Medical
INTERVIEW
Scott Ariagno
EdgeOne Medical
INTERVIEW with Scott Ariagno, EdgeOne Medical
Scott Ariagno talks exclusively with ONdrugDelivery's Guy Furness about the role that contract development organisations play in the drug delivery industry ecosystem and how independent expertise can enable companies like EdgeOne Medical to troubleshoot and accelerate product development.
FLUROTEC<sup>®</sup> PREFILLABLE SYRINGE PLUNGERS: A SOLUTION FOR LOW-TEMPERATURE STORAGE
INJECTION
Christa Janssen-Otten
West Pharmaceutical Services
FLUROTEC® PREFILLABLE SYRINGE PLUNGERS: A SOLUTION FOR LOW-TEMPERATURE STORAGE
Christa Jansen-Otten discusses how West Pharmaceutical Services' FluroTec plungers for prefilled syringe solutions can cope with cold storage conditions to extend drug shelf life and preserve integrity. 
ROUNDTABLE: DISCUSSION ON ANTI-OBESITY TREATMENTS
ROUNDTABLE
Stephen Perry
Kymanox
ROUNDTABLE: DISCUSSION ON ANTI-OBESITY TREATMENTS
Stephen M Perry, Mathias Romacker and Andreas Schneider tackle the subject of GLP-1s and related obesity-targeted injectable therapeutics and the enormous impact they are having and are expected still to have on drug delivery and the wider pharmaceutical sector.
COMPANY SHOWCASE: PCI PHARMA SERVICES
INDUSTRIALISATION
PCI Pharma Services
COMPANY SHOWCASE: PCI PHARMA SERVICES
As a trusted partner, PCI offers expertise and solutions in sterile fill-finish and specialist final assembly and packaging of advanced drug delivery and drug-device combination products, including seamless end-to-end injectable solutions.
FUTURE TRENDS FOR NOVEL INJECTABLE DRUG DELIVERY
EXPERT VIEW
Chris Hurlstone
FUTURE TRENDS FOR NOVEL INJECTABLE DRUG DELIVERY
Chris Hurlstone looks at the increasing demand for novel injectable devices and summarises the areas we can expect to see significant development activities in injectable technologies.
A NEW DIMENSION: BALANCING BIOLOGIC LIMITATIONS AND PATIENT PERCEPTIONS FOR AN ENHANCED INJECTION EXPERIENCE
INJECTION
Enrico Barichello
Stevanato Group
A NEW DIMENSION: BALANCING BIOLOGIC LIMITATIONS AND PATIENT PERCEPTIONS FOR AN ENHANCED INJECTION EXPERIENCE
Enrico Barichello and Carlo Valbonesi discuss the need to harmonise the formulation parameters with patient convenience and comfort for injections, and demonstrate how Stevanato Group has solved this issue through innovation in injector components.
THE PERFORMANCE OF EUROJECT – A BFS-BASED INJECTION DEVICE
PREFILLED SYRINGES
Nourhène Esseghir
Unither Pharmaceuticals
THE PERFORMANCE OF EUROJECT – A BFS-BASED INJECTION DEVICE
Nourhène Esseghir, Alexandre Fontayne and Laury Livemont discuss the performance and benefits of Unither's Euroject® injection system. 
BEYOND PROBABILITY: CHOOSING DETERMINISTIC METHODS FOR RELIABLE CONTAINER CLOSURE INTEGRITY TESTING
INJECTION
Antonio Scatena
Gateway Analytical
BEYOND PROBABILITY: CHOOSING DETERMINISTIC METHODS FOR RELIABLE CONTAINER CLOSURE INTEGRITY TESTING
Antonio Scatena answers some of the most common questions regarding the container closure integrity testing methods used to detect leaks and defects – and discusses how the industry can meet the updated expectations set by regulatory bodies.
DEFINING HIGH-VISCOSITY, LARGE-VOLUME DRUG DELIVERY SYSTEMS
EXPERT VIEW
Kyle Toole
DEFINING HIGH-VISCOSITY, LARGE-VOLUME DRUG DELIVERY SYSTEMS
Kyle Toole, Blair Hutton and James McLusky discuss the value that mathematical modelling can provide in the early stages of injectable drug delivery device development, especially when coupled with appropriate empirical testing in a laboratory setting.
PIONEERING PHARMACEUTICAL PACKAGING: A PUSH FOR DECARBONISATION AND CIRCULARITY
SUSTAINABILITY
Philipp Ludihuser
SCHOTT Pharma
PIONEERING PHARMACEUTICAL PACKAGING: A PUSH FOR DECARBONISATION AND CIRCULARITY
Philipp Ludihuser and Arne Kloke highlight how SCHOTT Pharma’s collaboration with customers and partners in the pharmaceutical industry reduces the carbon emissions from the production of vials, cartridges, ampoules and syringes, as well as introducing circular solutions to increase resource efficiency.
Top